| Income Statement |
| Total Revenue | 17.59M |
|
| Revenues (USD) | 17.59M |
| Cost of Revenue | 9.64M |
| Gross Profit | 7.96M |
| Operating Expenses | 5.13M |
| Research and Development Expense | 3.19M |
| Selling, General and Administrative Expense | 2.11M |
| Operating Income | 2.83M |
| Income Tax Expense | 703.00K |
| Net Income | 1.98M |
| Net Income Common Stock | 1.98M |
| Net Income Common Stock (USD) | 1.98M |
| Consolidated Income | 1.98M |
| Earnings per Basic Share | 0.25 |
| Earnings per Basic Share (USD) | 0.25 |
| Earnings per Diluted Share | 0.24 |
| Earning Before Interest & Taxes (EBIT) | 2.69M |
| Earning Before Interest & Taxes (USD) | 2.69M |
| Weighted Average Shares | 7.79M |
| Weighted Average Shares Diluted | 8.12M |
| Balance Sheet |
| Cash and Equivalents | 26.62M |
| Cash and Equivalents (USD) | 26.62M |
| Investments | 8.82M |
| Investments Current | 5.64M |
| Investments Non-Current | 3.18M |
| Trade and Non-Trade Receivables | 6.77M |
| Current Assets | 45.84M |
| Property, Plant & Equipment Net | 13.83M |
| Total Assets | 70.93M |
| Total Debt | 3.41M |
| Current Liabilities | 10.68M |
| Debt Non-Current | 3.41M |
| Total Liabilities | 14.61M |
| Accumulated Retained Earnings (Deficit) | 65.66M |
| Accumulated Other Comprehensive Income | -459.00K |
| Shareholders Equity | 56.32M |
| Shareholders Equity (USD) | 56.32M |
| Assets Non-Current | 25.09M |
| Total Debt (USD) | 3.41M |
| Deferred Revenue | 2.19M |
| Liabilities Non-Current | 3.94M |
| Trade and Non-Trade Payables | 1.71M |
| Cash Flow |
| Depreciation, Amortization & Accretion | 850.00K |
| Net Cash Flow / Change in Cash & Cash Equivalents | 4.55M |
| Capital Expenditure | -1.18M |
| Net Cash Flow from Investing | -1.16M |
| Net Cash Flow - Investment Acquisitions and Disposals | 17.00K |
| Net Cash Flow from Operations | 6.12M |
| Effect of Exchange Rate Changes on Cash | -400.00K |
| Share Based Compensation | 672.00K |